Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

156.94
-3.1000-1.94%
Pre-market: 156.13-0.8128-0.52%08:34 EDT
Volume:3.87M
Turnover:610.42M
Market Cap:243.41B
PE:23.49
High:159.13
Open:158.31
Low:156.74
Close:160.04
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.17
T/O Rate:0.26%
Dividend:3.17
Dividend Rate:2.02%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.84
PE(LYR):24.00

Loading ...

Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says

MT Newswires Live
·
Sep 04

AstraZeneca's New Lung Treatment Could Become Market Leader

Dow Jones
·
Sep 03

Berenberg Bank Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 03

AstraZeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

Deutsche Bank Sticks to Its Sell Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

AstraZeneca completes global license agreement for Zegfrovy in lung cancer

TIPRANKS
·
Sep 01

AstraZeneca Reports 'Meaningful Improvement' in Phase 3 Study of Lung Cancer Patients

MT Newswires Live
·
Sep 01

AstraZeneca Says Breast Cancer Combo Approved in EU; Completes Acquisition of License for Lung Cancer Treatment

MT Newswires Live
·
Sep 01

Movement Alert|AstraZeneca PLC Declines 4.14% Overnight, Competitive Threat From Summit Ivosdenib Data Weighs on Immuno-Oncology Outlook

Market Focus
·
Sep 01

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 01

Hutchmed Says Lung Cancer Therapy Improves Progression-Free Survival in China Phase 3 Trial

MT Newswires Live
·
Aug 31

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 29

Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data

TIPRANKS
·
Aug 28

AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial

TIPRANKS
·
Aug 28

AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma

TIPRANKS
·
Aug 28

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

TIPRANKS
·
Aug 27

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

TIPRANKS
·
Aug 27

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live
·
Aug 27

AstraZeneca's Tezspire Meets Esophagitis Late-Stage Trial Goals

Dow Jones
·
Aug 27